These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1426 related articles for article (PubMed ID: 31731384)
1. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma. Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384 [TBL] [Abstract][Full Text] [Related]
2. The identification of a common different gene expression signature in patients with colorectal cancer. Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244 [TBL] [Abstract][Full Text] [Related]
3. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics. Ni KW; Sun GZ Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633 [TBL] [Abstract][Full Text] [Related]
4. Bioinformatics analysis identified MMP14 and COL12A1 as immune-related biomarkers associated with pancreatic adenocarcinoma prognosis. Li Y; Su Z; Wei B; Qin M; Liang Z Math Biosci Eng; 2021 Jun; 18(5):5921-5942. PubMed ID: 34517516 [TBL] [Abstract][Full Text] [Related]
5. Identifying Ding J; Liu Y; Lai Y PeerJ; 2020; 8():e10419. PubMed ID: 33282565 [TBL] [Abstract][Full Text] [Related]
6. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis. Shang M; Zhang L; Chen X; Zheng S Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587 [TBL] [Abstract][Full Text] [Related]
7. Integrated bioinformatics analysis identified COL11A1 as an immune infiltrates correlated prognosticator in pancreatic adenocarcinoma. Zheng X; Liu X; Zheng H; Wang H; Hong D Int Immunopharmacol; 2021 Jan; 90():106982. PubMed ID: 33129696 [TBL] [Abstract][Full Text] [Related]
8. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics. Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138 [TBL] [Abstract][Full Text] [Related]
9. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis. Zhou J; Hui X; Mao Y; Fan L Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829 [TBL] [Abstract][Full Text] [Related]
10. Identification of hub genes and analysis of prognostic values in pancreatic ductal adenocarcinoma by integrated bioinformatics methods. Lu Y; Li C; Chen H; Zhong W Mol Biol Rep; 2018 Dec; 45(6):1799-1807. PubMed ID: 30173393 [TBL] [Abstract][Full Text] [Related]
11. Integrated bioinformatics analysis of potential biomarkers for pancreatic cancer. Shi H; Xu H; Chai C; Qin Z; Zhou W J Clin Lab Anal; 2022 May; 36(5):e24381. PubMed ID: 35403252 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and prognostic values of MET expression in pancreatic adenocarcinoma based on bioinformatics analysis. Yao Y; Zhan R; Gong C; Lv J; Lu X Medicine (Baltimore); 2023 Oct; 102(41):e34656. PubMed ID: 37832054 [TBL] [Abstract][Full Text] [Related]
13. Identification of key regulators of pancreatic ductal adenocarcinoma using bioinformatics analysis of microarray data. Li N; Zhao X; You S Medicine (Baltimore); 2019 Jan; 98(2):e14074. PubMed ID: 30633213 [TBL] [Abstract][Full Text] [Related]
14. Identification of Hub Genes and Pathways in Gastric Adenocarcinoma Based on Bioinformatics Analysis. Qiu J; Sun M; Wang Y; Chen B Med Sci Monit; 2020 Feb; 26():e920261. PubMed ID: 32058995 [TBL] [Abstract][Full Text] [Related]
15. ITGA2, LAMB3, and LAMC2 may be the potential therapeutic targets in pancreatic ductal adenocarcinoma: an integrated bioinformatics analysis. Islam S; Kitagawa T; Baron B; Abiko Y; Chiba I; Kuramitsu Y Sci Rep; 2021 May; 11(1):10563. PubMed ID: 34007003 [TBL] [Abstract][Full Text] [Related]
16. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer. Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489 [TBL] [Abstract][Full Text] [Related]
17. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus. Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912 [TBL] [Abstract][Full Text] [Related]
18. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma. Shi T; Gao G Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35083488 [TBL] [Abstract][Full Text] [Related]
19. Key genes associated with pancreatic cancer and their association with outcomes: A bioinformatics analysis. Wu J; Li Z; Zeng K; Wu K; Xu D; Zhou J; Xu L Mol Med Rep; 2019 Aug; 20(2):1343-1352. PubMed ID: 31173193 [TBL] [Abstract][Full Text] [Related]
20. Integrated Analysis of Hub Genes and Pathways In Esophageal Carcinoma Based on NCBI's Gene Expression Omnibus (GEO) Database: A Bioinformatics Analysis. Yu-Jing T; Wen-Jing T; Biao T Med Sci Monit; 2020 Aug; 26():e923934. PubMed ID: 32756534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]